The impact of ADHD medications on growth in children is a topic of concern and has been studied extensively. The two main classes of medications used to treat ADHD are stimulants (e.g., methylphenidate and amphetamines) and non-stimulants (e.g., atomoxetine). Here's an overview of the current understanding: 1. **Stimulant Medications:** - **Short-Term Effects:** Some studies have suggested a small reduction in growth velocity (rate of growth) during the first year of stimulant treatment. However, this effect is generally modest, and catch-up growth often occurs in subsequent years. - **Long-Term Effects:** The long-term impact on final adult height is less clear. Some studies have found that stimulant use during childhood is associated with a slight reduction in adult height, while others have not found a significant effect. 2. **Non-Stimulant Medications (e.g., Atomoxetine):** - **Growth Effects:** Atomoxetine, a non-stimulant medication commonly used for ADHD, generally does not appear to have a significant impact on growth. It's important to note that individual responses to medications can vary, and the decision to use ADHD medications should be made on a case-by-case basis, considering the potential benefits and risks. The potential impact on growth is just one factor to consider when evaluating treatment options for ADHD. Healthcare providers typically monitor the growth of children on ADHD medications and may adjust the treatment plan if growth concerns arise. They may also consider non-stimulant options for children who experience growth-related issues. If you have concerns about the potential impact of ADHD medications on your child's growth, it's crucial to discuss these concerns openly with your child's healthcare provider. They can provide personalized guidance based on the specific circumstances and health history of your child. It's also important to consider the broader context of ADHD treatment, as effective management of ADHD symptoms can have significant positive effects on a child's academic, social, and emotional well-being. Balancing the potential risks and benefits, along with regular monitoring, is key to optimizing the overall well-being of children with ADHD.